NCT00443482View on ClinicalTrials.gov

Study to Demonstrate Equivalence of Formoterol 12 and 24 µg Delivered Via Two Types of Single Dose Dry Powder Inhalers (Concept1 and Aerolizer)

PHASE2CompletedINTERVENTIONAL

Enrollment

50

Participants

Timeline

Start Date

February 28, 2007

Primary Completion Date

May 31, 2007

Study Completion Date

May 31, 2007

Conditions

Asthma

Interventions

DRUG

formoterol

Trial Locations (4)

Unknown

Novartis Investigative Site, Berlin

Novartis Investigative Site, Bovenden--Lengler

Novartis Investigative Site, Marburg

Novartis Investigative Site, Wiesbaden

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Novartis

INDUSTRY

NCT00443482 - Study to Demonstrate Equivalence of Formoterol 12 and 24 µg Delivered Via Two Types of Single Dose Dry Powder Inhalers (Concept1 and Aerolizer) | Biotech Hunter | Biotech Hunter